Erectile dysfunction as a marker for vascular disease

被引:27
|
作者
Billups K.L. [1 ]
机构
[1] The EpiCenter for Sexual Health & Medicine, 7455 France Avenue South, Suite 362, Edina, 55435, MN
关键词
Endothelial Cell Activation; Endothelial Dysfunction; Erectile Dysfunction; Penile Erection; Vascular Risk Factor;
D O I
10.1007/s11934-005-0039-9
中图分类号
学科分类号
摘要
A body of evidence from basic science and clinical research is emerging to provide a compelling argument for endothelial dysfunction as a central etiologic factor in the development of atherosclerosis and systemic vascular diseases (hypertension, dyslipidemia, diabetes, ischemic heart disease, stroke, or claudication). Erectile dysfunction (ED) is another prevalent vascular disorder that, like cardiovascular disease, is now thought to be caused by endothelial dysfunction. In fact, a burgeoning literature is now available that suggests that ED may be an early marker for atherosclerosis, cardiovascular risk, and subclinical systemic vascular disease. The emerging awareness of ED as a barometer for vascular health and occult cardiovascular disease represents a unique opportunity for primary prevention of vascular disease in all men. Although the implications of this relationship for primary and secondary prevention of cardiovascular disease are not fully appreciated, the available literature makes a strong argument for the role of ED as an early marker for the development of significant cardiovascular risk factors and cardiovascular disease. © 2005, Current Science Inc.
引用
收藏
页码:439 / 444
页数:5
相关论文
共 50 条
  • [31] Erectile Dysfunction as a Marker for Cardiovascular Disease Diagnosis and Intervention: A Cost Analysis
    Pastuszak, Alexander W.
    Hyman, Daniel A.
    Yadav, Naveen
    Godoy, Guilherme
    Lipshultz, Larry I.
    Araujo, Andre B.
    Khera, Mohit
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 (04): : 975 - 984
  • [32] Severe erectile dysfunction is a marker for hyperprolactinemia
    AM Johri
    JPW Heaton
    A Morales
    International Journal of Impotence Research, 2001, 13 : 176 - 182
  • [33] Severe erectile dysfunction is a marker for hyperprolactinemia
    Johri, AM
    Heaton, JPW
    Morales, A
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2001, 13 (03) : 176 - 182
  • [34] Erectile dysfunction as a marker of silent cardiovascular disease in type-2 diabetic patients. The DIVA (DIabetes and VAscular disease) study
    Gonzalez-Juanatey, J. R.
    Alegria Ezquerra, E.
    Gomis Barbera, R.
    Salvador Taboada, M. J.
    Casasnovas Lenguas, J. A.
    Lopez Garcia-Aranda, V.
    Acosta Delgado, D.
    Salvador Rodriguez, J.
    Hernandez Mijares, A.
    Matali Gilarranz, A.
    EUROPEAN HEART JOURNAL, 2008, 29 : 86 - 86
  • [35] Incidence of extragenital vascular disease in patients with erectile dysfunction of arterial origin
    Vicari, E
    Arcidiacono, G
    Di Pino, L
    Signorelli, S
    Arancio, A
    Sorrentino, F
    Battiato, C
    D'Agata, R
    Calogero, AE
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2005, 17 (03) : 277 - 282
  • [36] Incidence of extragenital vascular disease in patients with erectile dysfunction of arterial origin
    E Vicari
    G Arcidiacono
    L Di Pino
    S Signorelli
    A Arancio
    F Sorrentino
    C Battiato
    R D'Agata
    A E Calogero
    International Journal of Impotence Research, 2005, 17 : 277 - 282
  • [37] Erectile dysfunction as a marker of silent cardiovascular disease in type-2 diabetic patients in Spain. The DIVA (Diabetes and VAscular disease) study
    Ramon Gonzalez-Juanatey, Jose
    Alegria Ezquerra, Eduardo
    Gomis Barbera, Ramon
    Salvador Taboada, Maria Jesus
    Grigorian Shamagian, Lilian
    Casasnovas Lenguas, Jose Antonio
    Lopez Garcia-Aranda, Victor
    Acosta Delgado, Domingo
    Salvador Rodriguez, Javier
    Hernandez Mijares, Antonio
    Matali Gilarranz, Arantxa
    MEDICINA CLINICA, 2009, 132 (08): : 291 - 297
  • [38] Complexities of vascular intervention for erectile dysfunction
    Rogers, Jason H.
    EUROINTERVENTION, 2014, 10 (01) : 24 - 25
  • [39] COST SAVINGS ASSOCIATED WITH THE USE OF ERECTILE DYSFUNCTION AS A MARKER FOR CORONARY ARTERY DISEASE
    Pastuszak, Alexander W.
    Yadav, Naveen
    Lipshultz, Larry I.
    Khera, Mohit
    Araujo, Andre B.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 37 - 37
  • [40] Severe erectile dysfunction in coronary heart disease patients: a marker for poorer outcome
    Godinho, A. R.
    Rocha, A.
    Pestana, G.
    Tavares-Silva, M.
    Santoalha, J. M.
    Amorim, H.
    Cadilha, R.
    Araujo, V.
    Parada, F. P.
    Maciel, M. J.
    EUROPEAN HEART JOURNAL, 2014, 35 : 56 - 57